Showing results (51-60 of 98) with videos related to
Sort By:
Pageof 10
Gland Surgery|March 8, 2024
Application of a modified lateral thoracic artery perforator flap in partial breast defectsShengchao Huang, Pu Qiu, Zhongzeng Liang, et al.Nature Communications|February 9, 2020
Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activationJiajia Wang, Hanqing He, Binbin Chen, et al.NPJ Science of Food|April 4, 2026
Dietary silver nanoparticle supplementation induces Alzheimer-like lesions through Bifidobacterium deficiency-dominated gut microbiota dysbiosis and neuroinflammationRongshang Shou, Ziyue Wang, Zige Han, et al.Biomaterials|February 28, 2020
Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategyQuan Zhou, Chengyuan Dong, Wufa Fan, et al.Cancer Medicine|October 3, 2023
The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancerMingyu Wan, Yongfeng Ding, Xiaolu Ma, et al.Frontiers in Oncology|November 17, 2022
Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatmentMingyu Wan, Yongfeng Ding, Chenyu Mao, et al.Frontiers in Oncology|July 9, 2020
Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric CancerHuan Wang, Yongfeng Ding, Ning Li, et al.Current Oncology (Toronto, Ont.)|November 24, 2022
Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with ChemotherapyXiaolu Ma, Yongfeng Ding, Jiong Qian, et al.BMC Cancer|July 10, 2026
Prognostic value of tertiary lymphoid structures in high-risk esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapyDongdong Huang, Yuejun Han, Hui Wu, et al.Journal of Nanobiotechnology|November 22, 2021
Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancerSheng Zheng, Jiafeng Wang, Ning Ding, et al.Pageof 10